.There is a problem that the reduction rate of small items relatively increases compared to the financial impact by using the same formula for PVA negotiations. It was pointed out that the current PVA is operating too rigidly without reflecting the reality that medicines affect health insurance finances. Critics say that drugs that reduce health insurance finances are not considered or that the criteria for excluding PVA drug prices are unreasonable, adversely affecting sales of some drugs.

Professor Lee Jong-hyuk of Chung-Ang University, who was in charge of the presentation at the National Assembly's policy meeting on the 25th, made the remarks. The current PVA cuts and adjusts prices within the range